Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications

BACKGROUND: Monoclonal antibodies (mAbs) represent the most numerous and significant group of biotherapeutics. While mAbs have undoubtedly improved treatment for many chronic diseases, including inflammatory diseases, they are typically expensive for health care systems and patients. Consequently, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tubic, Biljana, Marković-Peković, Vanda, Jungić, Saša, Allocati, Eleonora, Godman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research @ Point of Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413607/
https://www.ncbi.nlm.nih.gov/pubmed/36204505
http://dx.doi.org/10.1177/23992026211027692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413607/
https://www.ncbi.nlm.nih.gov/pubmed/36204505
http://dx.doi.org/10.1177/23992026211027692

Ejemplares similares